Breast cancer risk following irradiation for Hodgkin's disease

Cancer Treatment Reviews

Volumn 26, Issue 4, 2000, Pages 291-302

  Clemons, M ^a   Loijens, L ^a   Goss, Paul ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Breast cancer; Hodgkin's disease; Radiation; Radiation induced cancer; Secondary malignancies

Indexed keywords

AGE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER RISK; CANCER SCREENING; FOLLOW UP; HODGKIN DISEASE; PRACTICE GUIDELINE; RADIATION CARCINOGENESIS; RADIATION DOSE; REVIEW; RISK ASSESSMENT;

EID: 0034254637     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1053/ctrv.2000.0174     Document Type: Review

References (85)

1. Tucker M. A., Coleman C. N., Cox R. S., Varghese A., Rosenberg S. A. Risk of second cancers after treatment for Hodgkin's disease. N Eng J Med. 318:1988;76-81.
2. Hoppe R. T. Hodgkin's disease: complications of therapy and excess mortality. Ann Onc. 8:1997;: 115-118.
3. Land C. E., Boice J. D., Shore R. E., Norman JE and Tokunaga M. Breast cancer risk from low-dose exposures to ionizing radiation- Results of parallel analysis of three exposed populations. J Nat Cancer Inst. 65:1980;353-368.
4. Land C. E. Low-dose radiation- A cause of breast cancer? Cancer. 46:1980;868-873.
5. Gervais-Fagnou D. D., Girouard C., Laperriere N., Pintilie M., Goss P. E. Breast cancer in women following supradiaphragmatic irradiation for Hodgkin's disease. Oncol. 57:1999;224-231.
6. Hudson M. M., Poquette C. A., Lee J., Greenwald C. A., Shah A., Luo X., Thompson E. I., Willimas J. A., Kun L. E., Crist W. M. Increased mortality after successful treatment for Hodgkin's disease. J Clin Oncol. 16:1998;3592-3600.
7. Wolden S. L., Lamborn K. R., Cleary S. F., Tate D. J., Donaldson S. S. Second cancers following pediatric Hodgkin's disease. J Clin Oncol. 16:1998;536-544.
8. Chung C. T., Bogart J. A., Adams J. F., Sagerman R. H., Numann P. J., Tassiopoulos A., Duggan D. B. Increased risk of breast cancer in splenectomized patients undergoing radiation therapy for Hodgkin's disease. Int J Radiat Oncol Biol Phys. 37:1997;405-409.
9. Tinger A., Wasserman T. H., Klein E. E., Miller E. A., Roberts T., Piephoff J. V., Kucik N. The incidence of breast cancer following mantle field radiation therapy as a function of dose and technique. Int J Radiat Oncol Biol Phys. 37:1997;865-870.
10. Bhatia S., Robison L. L., Oberlin O., Greenberg M., Bunin G., Fossati-Bellani F., Meadows A. T. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Eng J Med. 334:1996;745-751.
11. Mauch P. M., Kalish L. A., Marcus K. C., Coleman C. N., Shulman L. N., Krill E., Come S., Silver B., Canellos G. P., Tarbell N. J. Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome. Blood. 87:1996;3625-3632.
12. Salloum E., Doria R., Schubert W., Zelterman D., Holford T., Roberts K. B., Farber L. R., Kiehl R. K., Cardinale J., Cooper D. L. Second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation. J Clin Oncol. 14:1996;2435-2443.
13. van Leeuwen F. E., Klokman W. J., van't Veer M. B., Hagenbeel A., Krol A., Vetter U. Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood. J Clin Oncol. 18:2000;487-497.
14. Hancock S. L., Tucker M. A., Hoppe R. T. Breast cancer after treatment of Hodgkin's disease. J Nat Cancer Inst. 85:1993;25-31.
15. Prior P., Pope D. J. Hodgkin's disease: subsequent primary cancers in relation to treatment. Br J Cancer. 58:1988;512-517.
16. Curtis R. E., Boice J. D. Second cancers after radiotherapy for Hodgkin's disease [Comment]. N Eng J Med. 319:1988;244-245.
17. Kaldor J. M., Day N. E., Band P., Choi N. W., Clarke E. A., Coleman M. P., Hakama M., Koch M., Langmark F., Neal F. E. Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries. Int J Cancer. 39:1987;571-585.
18. Carey R. W., Linggood R. M., Wood W., Blitzer P. H. Breast cancer developing in four women cured of Hodgkin's disease. Cancer. 54:1984;2234-2236.
19. Swerdlow A. J., Barber J. A., Vaughan Hudson G., Cunningham D., Gupta R. K., Hancock B. W. Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment. J Clin Oncol. 18:2000;498-509.
20. Bannister L. H., Williams P. L. Integuental systems - skin and breast. Gray's Anatomy. 1995;Churchill Livingstone, New York. p. 375-424.
21. Dickson, R. B. Lippman, M. E. Growth factors and oncogenes. Powles, T. J.Smith, I. E. Medical Management of Breast Cancer. UK, Martin Dunitz, 5, 18, 1991.
22. Kuhns, J. G. Ackerman, D. M. Microscopic anatomy of the breast. Donegan, W. I.Spratt, J. S. Cancer of the Breast (4th ed.). Philadelphia, WB Saunders, 16, 21, 1995.
23. Dickson, R. B. Harris, J. R.Lippman, M. E.Morrow, M.Helman, S. Biochemical control of breast development. Diseases of the Breast. Philadelphia, Lippincott-Raven, 1996.
24. Sharpe C. R. A development hypothesis to explain the multicentricity of breast cancer. Can Med Assoc J. 159:1998;55-59.
25. Okey, A. B. Harper, P. A. Grant, D. M. Hill, R. P. Chemical and radiation carcinogenesis. Tannock, I. F.Hill, R. P. The Basic Science of Oncology (3rd ed.). New York, McGraw-Hill, 1998, 166, 196.
26. Ullrich R. L., Ponnaiya B. Radiation-induced instability and its relation to radiation carcinogenesis. [Review]. Int J Radiation Biol. 74:1998;747-754.
27. Cox R. Molecular mechanisms of radiation oncogenesis. Int J Rad Biol. 65:1994;57-64.
28. Goss P. E., Sierra S. Current perspectives on radiation-induced breast cancer. J Clin Oncol. 16:1998;338-347.
29. Wazer D. E., Band V. Molecular and anatomic considerations in the pathogenesis of breast cancer. Rad Onc Invest. 7:1999;1-12.
30. Eisen A., Weber B. Recent advances in breast cancer biology. Curr Opinion in Oncol. 10:1998;486-491.
31. Deng G., Lu Y., Zlotnikov G., Thor A. D., Smith H. S. Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science. 274:1996;2057-2059.
32. O'Connell P., Pekkel V., Fuqua S., Osborne C. K., Clark G. M., Allred D. C. Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci. J Nat Cancer Inst. 90:1998;697-703.
33. Weinstein I. B. The origins of human cancer: molecular mechanisms of carcinogenesis and their implications for cancer prevention and treatment - 27th GHA Clowes Memorial lecture. Cancer Res. 48:1988;4135-4143.
34. Tokunaga M., Land C. E., Tokuoka S., Nishimori I., Soda M., Akiba S. Incidence of female breast cancer among atomic bomb survivors, 1950-1985. Radiation Res. 138:1994;209-223.
35. Wazer D. E., Chu Q., Liu X., Gao Q., Safaii H., Band V. Loss of p53 protein during radiation transformation of primary human mammary epithelial cells. Molecular Cell Biol. 14:1994;2468-2478.
36. Inano H., Suzuki K., Onoda M., Yamanouchi H. Susceptibility of fetal, virgin, pregnant and lactating rats for the induction of mammary tumors by gamma rays. Radiation Res. 145:1996;708-713.
37. Yamanouchi H., Ishii-Ohba H., Suzuki K., Onoda M., Wakabayashi K., Inano H. Relationship between stages of mammary development and sensitivity to gamma-ray irradiation in mammary tumorigenesis in rats. Int J Cancer. 60:1995;230-234.
38. Cutuli B., Dhermain F., Borel C., de Larochefordiere A., Graic Y., de Lafontan B., Dilhyudy J. M., Mignotte H., Tessier E., Tortochaux J., N'Guyen T., Bey P., Le Mevel-Le Pourhiet A., Velten M., Arriagada R. Breast cancer in patients treated for Hodgkin's disease: clinical and pathological analysis of 76 cases in 63 patients. European J Cancer. 33:1997;2315-2320.
39. Dershaw D. D., Yahalom J., Petrek J. A. Breast carcinoma in women previously treated for Hodgkin disease: mammographic evaluation. Radiology. 184:1992;421-423.
40. Yahalom J., Petrek J. A., Biddinger P. W., Kessler S., Dershaw D. D., McCormick B., Osborne M. P., Kinne D. A., Rosen P. P. Breast cancer in patients irradiated for Hodgkin's disease: a clinical and pathologic analysis of 45 events in 37 patients. J Clin Oncol. 10:1992;1674-1681.
41. Janjan N. A., Wilson J. F., Gillin M., Anderson T., Greenberg M., Schewe K., Cox J. D. Mammary carcinoma developing after radiotherapy and chemotherapy for Hodgkin's disease. Cancer. 61:1988;252-254.
42. Anderson N., Lokich J. Bilateral breast cancer after cured Hodgkin's disease. Cancer. 65:1990;221-223.
43. Li F. P., Corkery J., Canellos G., Neitlich H. W. Breast cancer after Hodgkin's disease in two sisters. Cancer. 47:1981;200-220.
44. Colvett K. T. Bilateral breast carcinoma after radiation therapy for Hodgkin's disease. South Med J. 88:1995;239-242.
45. Geffen D. B., Krause I., Faermann S. Bilateral synchronous breast carcinoma with axillary node involvement fifteen years after radiotherapy for Hodgkin's disease [letter]. Acta Oncol. 31:1993;477-478.
46. Abeloff M. D. Vinorelbine (Navelbine) in the treatment of breast cancer: a summary. Sem Oncol. 22 (2 Suppl 5):1995;1-4.
47. Aisenberg A. C., Finkelstein D. M., Doppke K. P., Koerner F. C., Boivin J. F., Willett C. G. High risk of breast carcinoma after irradiation of young women with Hodgkin's disease. Cancer. 79:1997;1203-1210.
48. O'Brien P. C., Barton M. B., Fisher R. Breast cancer following treatment for Hodgkin's disease: the need for screening in a young population. Australasian Radiation Oncology Lymphoma Group (AROLG). Australasian Radiol. 39:1995;271-276.
49. Hildreth N. G., Shore R. E., Dvoretsky P. M. The risk of breast cancer after irradiation of the thymus in infancy. N Engl J Med. 321:1989;1281-1284.
50. Broerse J. J., van Bekkum D. W., Zurcher C. Radiation carcinogenesis in experimental animals. Experientia. 45:1989;60-69.
51. Greene M. H., Wilson J. Second cancer following lymphatic and hematopoietic cancers in Connecticut 1935-1982. Natl Cancer Inst Monogr. 68:1985;191-217.
52. Storm H., Prenner A. Second cancer following lymphatic and hematopoietic cancers in Denmark, 1943-1980. Natl Cancer Inst Monogr. 68:1985;389-410.
53. Cook K. L., Adler D. D., Lichter A. S., Ikeda D. M., Helvie M. A. Breast carcinoma in young women previously treated for Hodgkin disease. AJR. 155:1990;39-42.
54. Tester W. J., Kinsella T. J., Waller B., Makuch R. W., Kelley P. A., Glatstein E., DeVita V. T. Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience. J Clin Oncol. 2:1984;762-769.
55. Lundell M., Mattsson A., Hakulinen T., Holm L. E. Breast cancer after radiotherapy for skin hemangioma in infancy. Radiation Res. 145:1996;225-230.
56. Modan B., Chetrit A., Alfandary E., Katz L. Increased risk of breast cancer after low-dose irradiation. Lancet. 1:1989;629-631.
57. Hrubec Z., Boice J. D. Jr, Monson R. R., Rosenstein M. Breast cancer after multiple chest fluoroscopies: second follow-up of Massachusetts women with tuberculosis. Cancer Res. 49:1989;229-234.
58. Boice J. D. Jr, Preston D., Davis F. G., Monson R. R. Frequent chest X-ray fluoroscopy and breast cancer incidence among tuberculosis patients in Massachusetts. Radiation Res. 125:1991;214-222.
59. Mattsson A., Ruden B. I., Hall P., Wilking N., Rutqvist L. E. Radiation-induced breast cancer: long-term follow-up of radiation therapy for benign breast disease. J Natl Cancer Inst. 85:1993;1679-1685.
60. Boice J. D. Jr, Harvey E. B., Blettner M., Stovall M., Flannery J. T. Cancer in the contralateral breast after radiotherapy for breast cancer. N Engl J Med. 326:1992;781-785.
61. Oberlin O. Present and future strategies of treatment in childhood Hodgkin's lymphomas. Ann Oncol. 7:1996;S73-S78.
62. Wagner J. L., Thomas C. R. Jr, Koh W. J., Rudolph R. H. Carcinoma of the male breast: update 1994. Med Ped Oncol. 24:1995;123-132.
63. de la Rochefordiere A., Asselain B., Scholl S., Campana F., Ucla L., Vilcoq J. R., Durand J. C., Pouillart P., Fourquet A. Simultaneous bilateral breast carcinomas: a retrospective review of 149 cases. Int J Radiat Oncol Biol Phys. 30:1994;35-41.
64. Roubidoux M. A., Helvie M. A., Lai N. E., Paramagul C. Bilateral breast cancer: early detection with mammography. Radiology. 196:1995;427-431.
65. Harris K. M., Costa-Greco M. A., Baratz A. B., Britton C. A., Ilkhanipour Z. S., Ganott M. A. The mammographic features of the postlumpectomy, postirradiation breast. Radiographics. 9:1989;253-268.
66. Bassett L. W., Gambhir S. Breast imaging for the 1990s. Sem Oncol. 18:1991;80-86.
67. Harris R. Variations of benefits and harms of breast cancer screening with age. J Natl Cancer Inst Monogr. 22:1997;139-143.
68. Baines C. J., Miller A. B. mammography versus clinical examination of the breasts. J Natl Cancer Inst. 22:1997;125-129.
69. Thomas D. B., Gao D. L., Self S. G., Allsion C. J., Tao Y., Mahloch J., Ray R., Qin Q., Presley R., Porter P. Randomized trial of breast self-examination in Shanghai-Methodology and preliminary results. J Natl Cancer Inst. 89:1997;355-365.
70. Baines C. J. Reflections on breast self examination [editorial]. J Natl Cancer Inst. 89:1997;339-340.
71. Peters M. H., Indukumar M. S., Batra M. K. Breast cancer in women following mantle irradiation for Hodgkin's disease. Am Surg. 61:1995;763-766.
72. Harris K. M., Vogel V. G. Breast cancer screening. Cancer Met Reviews. 16:1997;231-262.
73. Smith R. A. Screening fundamentals. J Natl Cancer Inst Monogr. 22:1997;15-19.
74. Baines C. J. Menstrual cycle variation in mammographic breast density: so who cares? [editorial comment]. J Natl Cancer Inst. 90:1998;875-876.
75. Armstrong B. R. Oestrogen therapy after menopause - boon or bone? Med J Australia. 148:1988;213-217.
76. Lancet. 350:1997;1047-1059.
77. Steinberg K. K., Thacker S. B., Smith S. J. A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA. 265:1991;1985-1990.
78. Sillero-Arenas M., Delgado-Rodriguez M., Rodigues-Canteras R., Bueno-Cavanillas A., Galvez-Vargas R. Menopausal hormone replacement therapy and breast cancer: a meta-analysis. Obstet Gynecol. 79:1992;286-294.
79. Colditz G. A. Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer. J Natl Cancer Inst. 90:1998;814-823.
80. Brinton L. A., Schairer C. Estrogen replacement therapy and breast cancer risk. Epidemiol Rev. 15:1993;66-79.
81. Colditz G. A. Hormone replacement therapy increases the risk of breast cancer. Ann NY Acad Sci. 833:1997;129-136.
82. Fisher B., Costantino J. P., Wickerham D. L. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 90:1998;1371-1388.
83. Veronesi U., Maisonneuve P., Costa A. Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Lancet. 352:1998;93-97.
84. Powles T., Eeles R., Ashley S. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial. Lancet. 352:1998;98-101.
85. Jordan V. C., Glusman J., Eckert S. Raloxifene reduces incident primary breast cancer. Integrated data from multicentre, double-blind, placebo-controlled, randomized trials in postmenopausal women. Breast Cancer Treatment Rev. 1998.